![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
STRATEGY Studies (GS-115 and GS-121):
Safety Analysis of Switching to STB from a RTV-Boosted PI or NNRTI Plus TVD Regimen
|
|
|
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
A Mills1, B Wade2, J Arribas3, A Pozniak4, M Bloch5, L Dau6, W Garner6, J Szwarcberg6, D Piontkowsky6
1Anthony Mills MD Inc., Los Angeles, CA, USA; 2Infectious Diseases Associates of NW Florida, USA; 3Hospital Universitario La Paz, Madrid, Spain; 4Chelsea and Westminster Hospital, London, UK;
5Holdsworth House Medical Practice, Sydney, Australia; 6Gilead Sciences, Inc., Foster City, CA, USA
![IAC1.gif](../images/072814/072814-2/IAC1.gif)
![IAC2.gif](../images/072814/072814-2/IAC2.gif)
![IAC3.gif](../images/072814/072814-2/IAC3.gif)
![IAC4.gif](../images/072814/072814-2/IAC4.gif)
![IAC5.gif](../images/072814/072814-2/IAC5.gif)
![IAC6.gif](../images/072814/072814-2/IAC6.gif)
![IAC7.gif](../images/072814/072814-2/IAC7.gif)
![IAC8.gif](../images/072814/072814-2/IAC8.gif)
![IAC9.gif](../images/072814/072814-2/IAC9.gif)
![IAC10.gif](../images/072814/072814-2/IAC10.gif)
![IAC11.gif](../images/072814/072814-2/IAC11.gif)
![IAC12.gif](../images/072814/072814-2/IAC12.gif)
![IAC13.gif](../images/072814/072814-2/IAC13.gif)
![IAC14.gif](../images/072814/072814-2/IAC14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|